Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Bristol-Myers recalls about 100,000 Excedrin bottles; some mistakenly contain NoDoz.

This article was originally published in The Tan Sheet

Executive Summary

BRISTOL-MYERS' EXCEDRIN RECALL of two lots, or about 100,000 bottles, of Aspirin-Free Excedrin Extra Strength Geltabs was initiated after the firm discovered that some of the bottles mistakenly contained NoDoz caplets. The switch was the result of a packaging snafu at the firm's Morrisville, N.C. facility; the Excedrin products packaged followed a NoDoz caplets on the same manufacturing line.
Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

PS085368

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel